The remarkable regenerative capacity of the zebrafish has made it an important model organism for studying heart regeneration. However, current loss-of-function studies are limited by a lack of conditional-knockout and effective gene-knockdown methods for the adult heart. Here, we report a novel siRNA knockdown method facilitated by poly(ethylene glycol)-b-poly(D,L-lactide) (PEG-PLA) nanoparticles. The siRNA-encapsulated nanoparticles successfully entered cells and resulted in remarkable gene-specific knockdown in the adult heart. This effect was demonstrated by down-regulation of the Aldh1a2 and Dusp6 proteins after intrapleural delivery of nanoparticle-encapsulated siRNAs. Furthermore, siRNA-mediated knockdown of Aldh1a2 was sufficient to inhibit myocardial proliferation and decrease the numbers of Gata4-positive cardiomyocytes after ventricular resection. Therefore, the results of this work demonstrate that nanoparticle-facilitated siRNA delivery provides an alternative tool for loss-of-function studies of genes in the adult heart in particular and other organs in general in the adult zebrafish.
Introduction
Heart disease has become a major devastating health issue, leading to salient mortality and a tremendous economic burden around the world (Go et al., 2014) . Mammals, including human beings, have a very limited capacity to repair the heart after myocardial infarction. Instead of producing new cardiomyocytes, the injury is normally replaced by non-contractile scar tissues, and this often leads to heart failure. In contrast, the adult zebrafish regenerates its heart perfectly after ventricular resection, cryoinjury, or genetic depletion of cardiomyocytes, making it an ideal model organism for investigating the molecular mechanisms underlying heart regeneration (Chablais et al., 2011; Gonzalez-Rosa et al., 2011; Parente et al., 2013; Poss et al., 2002; Raya et al., 2003; Schnabel et al., 2011; Wang et al., 2011) . However, a lack of conditional-knockout and effective gene-knockdown methods for adult organs remains a bottleneck for mechanistic studies in zebrafish. Currently, pharmacological inhibitors and the transgenic expression of dominant-negative mutants are primarily used to investigate gene function during regeneration of the adult zebrafish heart (Han et al., 2014; Jopling et al., 2010; Lepilina et al., 2006) . However, not all genes or signal pathways have dominantnegative mutants or pharmacological inhibitors; and the zebrafish heat-shock promoter, which is used to drive transgene expression, is frequently silenced in the adult zebrafish heart (unpublished observations). Therefore, an efficient gene-knockdown in the adult heart in particular, and other organs in general, is urgently needed.
Since the discovery of RNA interference in 1998, small-interfering RNAs (siRNAs) have been widely used for loss-of-function analysis in mammalian cells and model organisms (McManus and Sharp, 2002) , as well as for treating numerous diseases in animal models (de Fougerolles et al., 2007; Kim and Rossi, 2007; McCaffrey et al., 2003; Raoul et al., 2005) . Among these applications, siRNAs are capable of effectively silencing target genes in tumors (Hu-Lieskovan et al., 2005; Schiffelers et al., 2004; Yang et al., 2011) and in mammalian cardiomyocytes (Ko et al., 2009; Liu et al., 2013; Nam et al., 2012 Nam et al., , 2010 Won et al., 2013) with the assistance of different delivery systems. Based on our previous work in mammalian cells (Yang et al., 2011) , we report here on developing effective siRNA-knockdown of genes in the adult zebrafish heart, aided by cationic lipid-assisted poly(ethylene glycol)-b-poly(D,Llactide) (PEG-PLA) nanoparticles. 2. Materials and methods
Preparation of PEG-PLA nanoparticle-encapsulated siRNA
PEG-PLA nanoparticles loaded with siRNA were prepared using a double emulsion-solvent evaporation technique as previously described (Yang et al., 2011) . Briefly, 0.2 mg siRNA in 25 μL RNasefree water was first emulsified by sonication for 60 s over an ice bath in 0.5 ml chloroform containing 1.0 mg BHEM-Chol and 25 mg PEG 5k -PLA 11k . This primary emulsion was further emulsified by sonication (80 W for 1 min) in 5 mL RNase-free water over an ice bath to form a water-in-oil-in-water emulsion. The mixture was then added to a 50-mL round-bottom flask, and the solvent (chloroform and RNase-free water) was concentrated under reduced pressure by a rotary evaporator to a volume of 1 mL. The siRNA encapsulation efficiency, zeta potential, and particle size measurements were conducted according to a high-performance liquid chromatography procedure or using a Malvern Zetasizer Nano ZS90, as previously reported (Yang et al., 2011) .
The fluorescence-labeled cy5-siRNAs were: negative control siRNA with a scrambled sequence (antisense strand, 5′-ACGUGACACGUUCGGAGAAdTdT-3′), siRNA targeting Aldh1a2 mRNA (siAldh1a2, antisense strand, 5′-UUCAGGACAACCGUGUUCCTT-3′, siAldh1a2-2, antisense strand, 5′-UUUGUCUAUGCCCAUGUGCTT-3′) and siRNA targeting Dusp6 mRNA (siDusp6, antisense strand, 5′-AACUGCUGCUUGACGAACCTT-3′, siDusp6-2, antisense strand, 5′-AUCCAGGUUUGUGGAGUCCTT′). These siRNAs were synthesized by Shanghai Jima Life Science Co. (Shanghai, China).
Zebrafish husbandry
Zebrafish were raised and handled according to protocols approved by the Peking University Animal Care and Use Committee in a facility that is fully accredited by the AAALAC. Wild-type TL and Tg (gata4: EGFP) transgenic zebrafish lines at 6-12 months of age were used for heart surgery. The Tg (gata4: EGFP) transgenic zebrafish were generously provided by Dr. Todd Evans (Cornell University Medical Center, New York, NY) (Heicklen- Klein and Evans, 2004) . Tg(flk1: EGFP) fish was provided by Dr. Feng Liu (Institute of Zoology, Chinese Academy of Sciences, Beijing, China). Tg(myl7:EGFP) and Tg(tcf21:DsRed) zebrafish lines were from Dr. Geoffrey Burns (Massachusetts General Hospital, Charlestown, MA) (Burns et al., 2005; Kikuchi et al., 2011) .
Adult zebrafish heart resection
Ventricular resection was carried out mainly as previously described (Han et al., 2014; Poss et al., 2002) . Briefly, after anesthesia in tricaine, the zebrafish was placed supinely into the groove of a sponge. The pericardial sac was exposed by removing the surface scales and a small piece of skin using iridectomy scissors. The pericardial sac was opened with the aid of tweezers, and the apex of the ventricle was gently pulled up and cut with Vannas scissors. Immediately after ventricular resection, a small piece of wet paper tissues was placed on the ventricular wound. The bleeding ceased very quickly (within 10-15 s) due to the formation of blood clots. The fish was put back into a water tank, and water was puffed over the gills with a plastic pipette until it breathed and swam normally. The surface wound sealed within a few days.
BrdU incorporation and siRNA treatments
After ventricular resection, zebrafish were allowed to recover for 1 day. Fifty microliters of 2.5 mg/ml BrdU (B5002; Sigma; St. Louis, MO) was then co-injected with 5 μM nanoparticle-encapsulated siRNA (CY5-labeled, siAldh1a2, or siDusp6 siRNA), or 5 μM naked siRNA (CY5-labeled, siAldh1a2, or siDusp6 siRNA), or scrambled negative control. siRNAs was microinjected into the thoracic cavity once daily until the hearts were collected. For Supplemental Fig. S6E -J, BrdU was injected once a day from 10 to 14 dpa. For Supplemental Fig. S7 , five microliters of 5 μM nanoparticle-encapsulated siAldh1a2 (siAldh1a2), or 5 μM negative control siRNA with a scrambled sequence (siN.C.) were injected from 1 to 9 dpa; and five microliters of siAldh1a2 or siN.C. and 2.5 mg/ml BrdU (B5002; Sigma; St Louis, MO) were then co-injected into the thoracic cavity from 10 to 14 dpa. To optimize the injection volume, we injected 5, 10, or 20 μl of 0.5% phenol red (P0290; Sigma) into the thoracic cavity and then monitored the leakiness, noting that 10 μl is the maximal volume for the thoracic cavity in zebrafish.
Western blotting
Zebrafish hearts were homogenized in cell lysis buffer (P0013; Beyotime, Beijing, China) with the addition of a protease inhibitor cocktail (P8340; Sigma) and PhosStop phosphatase inhibitor cocktail (04906845001; Roche). Proteins were quantified with a BCA kit (PA115; Tiangen Biotech, Beijing, China), resolved on 10% SDS-PAGE gels, and transferred onto PVDF membranes (162-0177; Bio-rad). The membranes were then incubated with primary antibody and then with the corresponding HRP-conjugated secondary antibody. Proteins were detected with ECL western blotting substrates (W1001; Promega).
Immunostaining and histology
Adult hearts were immersed in 4% paraformaldehyde at room temperature for 2 h, and paraffin embedding and sectioning (4 μm) were performed followed by dehydration in a series of ethanols. The primary antibodies were anti-BrdU (B8434; Sigma), anti-Mef2C (sc-313; Santa Cruz), anti-GFP (A-11122; Invitrogen), anti-GAPDH (sc-166545; Santa Cruz), MF20 (Developmental Studies Hybridoma Bank), anti-Dusp6 (WH0001848M1; Sigma), anti-β-actin (4967; Cell Signaling) and anti-Aldh1a2 (P30011; Abmart).
The secondary antibodies used for immunostaining were Alexa Fluor 488 goat anti-mouse IgG (A21121; Invitrogen), Alexa Fluor 488 goat anti-rabbit IgG (A11034; Invitrogen), Alexa Fluor 555 goat anti-mouse IgG (A21424; Invitrogen), and Alexa Fluor 555 goat anti-rabbit IgG (A21428; Invitrogen). The secondary antibodies for western blotting were HRP goat anti-rabbit IgG (sc-2004; Santa Cruz) and HRP goat anti-mouse IgG (sc-2005; Santa Cruz).
Cryosections and confocal imaging
SiRNA-coupled nanoparticles were injected intrapleurally at 2.5 mg/kg of body weight. After the hearts were removed from anesthetized fish at given time-points, they were immediately immersed in phosphate buffer solution (PBS) and examined under an in vivo imaging system (Kodak In-Vivo Imaging System FX Pro, Carestream Health, USA) to detect the CY5 fluorescence signal. The tissues were then placed in the tissue cassettes, embedded in OCT, and frozen on a piece of foam floating on liquid nitrogen until the OCT solidified. The samples were then cut into 6-μm sections and collected on glass slides. DAPI was used to label the nuclei and the cryosections were examined under a confocal microscope (Zeiss 510; Zeiss, Germany).
Statistical analysis
Data are expressed as the mean 7SEM. Statistical comparisons were carried out using two-tailed Student's t-test analysis of variance. For Supplemental Fig. S6K , statistic significance between groups was determined with One-Way ANOVA. P o0.05 was considered to be statistically significant.
Results and discussion
Our previous studies have demonstrated the utility of PEG-PLA nanoparticles for the systemic delivery of siRNAs in cancer therapy (Liu et al., 2013; Yang et al., 2011) . Here, we redesigned this methodology for siRNA delivery to the adult zebrafish heart after ventricular resection (Fig. 1) . As described previously (Yang et al., 2011) , the structures of PEG-PLA and BHEM-Chol, as well as the preparation of siRNA-loaded particles are illustrated (Fig. 1A) . The encapsulation efficiency of siRNA was 50% in the formulation, in which the weights of siRNA, BHEM-Chol, and PEG 5K -PLA 25K were 0.2 mg, 1.0 mg and 25 mg, respectively. The diameter of the siRNAloaded particles was 125 nm with the minimally-required ratios, which were determined using a zeta-potential analyzer with dynamic light-scattering. The corresponding zeta-potential of these particles was 23 mV. The siRNA-loaded particles were prepared one day after ventricular resection. Six-month-old wild-type TL zebrafish were subjected to ventricular resection, and siRNA particles with or without BrdU were then co-injected intrapleurally once daily until the hearts were harvested for whole-heart imaging, western blotting, and/or immunostaining (Fig. 1B) .
To determine the efficiency of delivery of PEG-PLA nanoparticle-encapsulated siRNA, we intrapleurally injected CY5-labeled siRNA and measured the fluorescence signal in injured zebrafish hearts. After ventricular resection, we detected a CY5-siRNA fluorescence signal 3 h post injection (hpi), which was barely attenuated at 24 h, while there was no detectable fluorescence signal in either water-injected (mock) or naked siRNA-injected hearts ( Fig. 2A; Supplemental Fig. S1B ). Cumulative, steady signals in the heart at 24 h after siRNA administration suggested that nanoparticle-encapsulated siRNA was gradually released ( Fig. 2A and B) . The fluorescent signals then declined from 1 to 3 dpi (Supplemental Fig. S1C ). In addition, we found that CY5-siRNA was also accumulated in isolated intestine and liver but less in isolated kidney and spleen (Supplemental Fig. S1A ). To verify this conclusion from in vivo whole-heart imaging, we determined the subcellular localization of CY5-siRNA after nanoparticlemediated delivery using laser-scanning confocal microscopy. Nanoparticle-encapsulated CY5-labeled siRNA was injected 1 day after ventricular resection, and cryosections of the injured hearts were then prepared for immunostaining at the indicated time points ( Fig. 2C-H; Supplemental Fig. S2A-C) . CY5-siRNA was found primarily in the cytoplasm and not in the DAPI-labeled nuclei, which is consistent with our previous finding that PEG-PLA nanoparticle-encapsulated siRNA is localized in lysosomes in mammalian cells (Yang et al., 2011) . Encapsulated siRNA entered all three types of cells in the heart we examined, including Tg(myl7: EGFP)-labeled cardiomyocytes, Tg(flk1:EGFP)-labeled endocardium, and Tg(tcf21:DsRed)-labeled epicardium (Supplemental Fig. S2 ), suggesting no preference in entering a particular cell type by this nanoparticle-mediated siRNA delivery. Similar to in vivo whole-heart imaging data, we found a strong fluorescence Fig. 1 . Overview of preparation and delivery of nanoparticle-encapsulated siRNAs into zebrafish hearts after ventricular resection. (A) Schematic of preparing encapsulated siRNA facilitated by cationic lipids (BHEM-Chol) and PEG-PLA using a double-emulsion method (Yang et al., 2011) . (B) Experimental design: (1) wild-type TL zebrafish at 6-month old (6 m) were subjected to ventricular resection; (2) microinjection of encapsulated CY5-labeled siRNA into the heart after ventricular resection at 1 dpa; (3) examination of CY5-labeled siRNA entering cardiac cells using an imaging system and confocal microscopy; (4) western blot and immunostaining to confirm siRNA-mediated gene knockdown; and (5) functional analysis of the effects of siRNA knockdown on heart regeneration, using BrdU þ /Mef2c þ proliferating cardiomyocytes and Gata4-EGFP cardiomyocytes.
signal at 3 h post-injection, which remained unchanged for 24 h (Fig. 2E-H) while there was no detectable fluorescence signal in either water-injected (mock) or naked siRNA-injected hearts (Fig. 2C, D and H) . Taken together, these data suggested that PEG-PLA nanoparticles effectively facilitated the delivery of siRNAs into the adult zebrafish heart after injury. We then asked whether the PEG-PLA nanoparticle-encapsulated siRNA efficiently causes gene-specific knockdown. We targeted two known genes, Aldh1a2 (retinoic acid (RA)-synthesizing enzyme) and dusp6 (also known as MAP-kinase phosphatase, mkp3), both of which are up-regulated during zebrafish heart regeneration (Han et al., 2014; Kikuchi et al., 2011) . Immunostaining showed that siAldh1a2 inhibited Aldh1a2 expression ( Fig. 3B and B′) compared with the negative control siRNA (siN.C.) group (Fig. 3A and A′) at 2 days post amputation (dpa). Western blotting provides further evidence that siAldh1a2 inhibited Aldh1a2 but neither the negative control nor naked siAldh1a2 had any effect on Aldh1a2 expression at 2 dpa ( Fig. 3C  and D) . Importantly, the injury-induced expression of Aldh1a2 in siAldh1a2-treated hearts was reduced to a level comparable to that in sham hearts, suggesting that nanoparticle-mediated siAldh1a2-knockdown is highly efficient. Similarly, both immunostaining and western blotting showed that siDusp6 also specifically suppressed Dusp6 expression compared with that in the negative control and naked siDusp6 groups (Fig. 3E-H) . The siDusp6 attenuated the induction of Dusp6 after ventricular resection to the similar level as that in sham hearts, further substantiating the efficiency of knockdown. Furthermore, the siDusp6-mediated knockdown led to increased pErk in injured heart at 2 day post-injection of encapsulated siRNAs (Supplemental Fig.  S2 ). Statistic analysis showed that the siRNA-silencing efficacy reached 450% for both genes (Fig. 3D and H) . Second siRNAs, Fig. 2 . Effective nanoparticle-assisted delivery of siRNA into the adult zebrafish heart. (A) Fluorescence images of CY5-siRNA accumulation in isolated zebrafish heart under the in vivo imaging system. Note that fluorescence signals were hardly detectable in the negative control (Mock) and unencapsulated siRNA (Naked) groups at 24 hpi, and were increased in the nanoparticle-encapsulated siRNA groups from 3 to 24 hpi. An arbitrary scale of fluorescence signal is shown from blue (low) to red (high). (B) Quantification of CY5-siRNA in heart tissues using the in vivo imaging system (*P o 0.05). (C-G) Fluorescent images of cryosections of heart tissues under confocal microscopy. Note the clear CY5-siRNA signal in the experimental group at 3, 6 and 24 hpi but very little signal in the negative control (Mock) and naked siRNAs (Naked) groups at 24 hpi. Enlarged siRNA localization is shown (E-G, low-right corner). DAPI was used to stain nuclei. Scale bar, 50 μm. siAldh1a2-2 and siDusp6-2, for each of the two genes were also found to have gene-specific knockdown for Aldh1a2 and Dusp6 similar to those with siAldh1a2 and siDusp6 by immunostaining and western blots (Supplemental Fig. S3 ). Furthermore, encapsulated siAldh1a2-2 inhibited the Mef2C þ /BrdU þ proliferating cardiomyocytes while it had no effect on cell apoptosis in the heart (Supplemental Fig. S4 ). In addition, daily injection of scrambled siRNA (siN.C.) had no apparent effect on cardiac fibrosis at 30 dpa (Supplemental Fig. S6A-D) . To minimize the injection volume, we found the thoracic cavity could hold the maximal amount of 10 μl phenol red in zebrafish (Supplemental Fig. S7A-C) , suggesting that the majority of injected volume leaked out when we injected 50 μl siRNA. Indeed, we found that 5 μl siAldh1a2 knockdown had similar effect on Mef2C þ /BrdU þ proliferating cardiomyocytes as 50 μl siAldh1a2 injections (Supplemental Fig. S7 ; Fig. 4C , D and F).
Taken together, just as in mammalian cells (Yang et al., 2011) , PEG-PLA nanoparticle-mediated siRNAs achieved specific knockdown of their target genes, aldh1a2 and dusp6, in the adult heart. We further asked whether siRNA-mediated knockdown of aldh1a2 had functional consequences during zebrafish heart regeneration. Poss and colleagues have shown that aldh1a2 is activated in the endocardium and epicardium and RA signaling is essential for myocardial proliferation during zebrafish heart regeneration . To determine whether the reduced Aldh1a2 protein levels caused by nanoparticle-mediated siRNA knockdown were sufficient to interfere with RA synthesis/ signaling, we intrapleurally injected encapsulated siAldh1a2 once a day after ventricular amputation and collected the hearts at 14 dpa for analyses. Gata4-GFP myocytes have been shown to be actively involved in myocardial regeneration in zebrafish (Han et al., 2014; Kikuchi et al., 2011) . We found that Gata4-GFP myocytes significantly decreased in the siAldh1a2-treated group compared with that in the negative control group (Fig. 4A, B and E), suggesting that the RA signaling was compromised by siAldh1a2 treatment. Furthermore, siAldh1a2 reduced the cardiomyocyte proliferation index (8%) after 14-day of siAldh1a2 administration compared with that (15%) in the negative control group (Fig. 4C , C′, C″, C‴, D, D′, D″, D‴, and F). Together, our data support the conclusion that the PEG-PLA nanoparticle-encapsulated siRNA efficiently decreased the targeted Aldh1a2 protein levels and led to functional disruption of RA signaling during heart regeneration.
Briefly, we have developed a new loss-of-function method for silencing specific genes during regeneration in the adult zebrafish heart, using a PEG-PLA copolymer along with an amphiphilic and cationic lipid. This siRNA-delivery system efficiently transferred siRNA into the heart tissue and escaped from endosomes, and in turn had notable gene-specific knockdown effects. Moreover, the siRNA knockdown was capable of interfering with the RA signaling that is normally required for heart regeneration, as demonstrated by the reduction of both Mef2C/BrdU-positive and Gata4-GFPpositive cardiomyocytes. This functional interference on cardiomyocyte proliferation indices with RA signaling is a little less potent than that induced by transgenic overexpression of dominantnegative RA receptors or RA-degrading enzymes in adult zebrafish heart . Therefore, this work presents a simple, efficient siRNA-delivery and gene-knockdown method, which will be invaluable for loss-of-function analyses in the heart in particular and likely for other organs of adult zebrafish. This method provides an alternative, important tool for functional studies of genes in adult organs of vertebrate animals such as zebrafish, in which conditional-knockout methods are not available.
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